Lessons Learned from COVID: Improvements in Cannabis Testing Discussed by Bernie Lorenz, PhD
May 10th 2024In the Cultivation Track at Cannabis Science Conference, Bernie Lorenz, Chief Science Officer of ProKure Solutions, discussed the intriguing topic of the effects of COVID on cannabis testing methods.
DEA Will Reclassify Cannabis to Schedule III, According to Reports
April 30th 2024Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.
The Latest Challenges to Cannabis Analysis: Perspectives from Zacariah Hildenbrand
April 24th 2024Our sister publication, LCGC International, sat down with Zacariah Hildenbrand, PhD, Chief Science Officer of Infinity Water Solutions and Partner of Medusa Analytical, for more insight into various trends in cannabis testing.